Literature DB >> 1249522

Studies on the mechanism of solubilization of immune precipitates by serum.

J Czop, V Nussenzweig.   

Abstract

Antigen (Ag)-antibody (Ab) aggregates prepared with several different antigens are solubilized by fresh serum at 37 degrees C (complex-release activity of serum or CRA). The rate of solubilization varies in different systems and is strongly influenced by the affinity of Ab for the Ag in the immune precipitate. With a given Ag-Ab precipitate, the maximum amount of complex that can be solubilized by individual sera is independent of the initial concentration of complexes and cannot be increased by prolonged incubation. CRA occurs in the absence of C2 and C4, but not in the absence of C3 and factor B of the properdin pathway. Addition of C2 to C2-deficient serum or C4 to C4-deficient serum enhances CRA. Solubilization does not involve extensive degradation of the complexed antibody, as might be detected by acrylamide gel electrophoresis of released antibody after reduction and alkylation to separate H and L chains. Immune precipitates can also be solubilized by incubation with monovalent fragments (Fab or Fab') of antibodies against determinants of the Ab molecules in the immune precipitate. In contrast, F(ab')2 fragments decrease the solubility of the immune precipitates. In view of these findings, we propose that CRA is mediated by the binding of functionally monovalent C fragments (C3 and C4) onto Ab molecules in the precipitates.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249522      PMCID: PMC2190136          DOI: 10.1084/jem.143.3.615

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Mechanism of binding of soluble immune complexes to lymphocytes.

Authors:  A Eden; C Bianco
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  The specific capsular polysaccharide of type VII Pneumococcus.

Authors:  J M Tyler; M Heidelberger
Journal:  Biochemistry       Date:  1968-04       Impact factor: 3.162

4.  The relationship between antibody affinity and the efficiency of complement fixation.

Authors:  A S Fauci; M M Frank; J S Johnson
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  Complement as a regulator of interactions between immune complexes and cell membranes.

Authors:  G W Miller; V Nussenzweig
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

6.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

7.  Modification of arginine in the active sites of antibodies.

Authors:  A L Grossberg; D Pressman
Journal:  Biochemistry       Date:  1968-01       Impact factor: 3.162

8.  Complete absence of the third component of complement in man.

Authors:  M Ballow; J E Shira; L Harden; S Y Yang; N K Day
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Complement-dependent release of immune complexes from the lymphocyte membrane.

Authors:  G W Miller; P H Saluk; V Nussenzweig
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  50 in total

1.  Immune complex-FcgammaR interaction modulates monocyte/macrophage molecules involved in inflammation and immune response.

Authors:  P Barrionuevo; M Beigier-Bompadre; G C Fernandez; S Gomez; M F Alves-Rosa; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

2.  Dissociation of IgG antibody-mediated clumps of Trypanosoma brucei gambiense by complement.

Authors:  T Takayanagi; H Kawaguchi; Y Yabu; M Itoh; K Yano
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.

Authors:  E R Holme; J Veitch; A Johnston; I C McKay; K Whaley
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 4.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

5.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

6.  Plasmapheresis in systemic lupus erythematosus.

Authors:  C J Moran; H F Parry; J Mowbray; J D Richards; A H Goldstone
Journal:  Br Med J       Date:  1977-06-18

7.  Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.

Authors:  A Gabriel; V Agnello
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

10.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.